Development of an precision gene engineered B cell medicine that produces highly active and sustained levels of acid sphingomyelinase for the treatment of Neimann-Pick disease

Acid sphingomyelinase
DOI: 10.1016/j.ymgme.2023.107975 Publication Date: 2024-01-31T20:44:36Z